Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EZE-TRACK: Predictors of Lipid Response to Ezetimibe
NCT07839741Phase 4Recruiting
- Sponsor
- University of Porto
- Start
- Jun 2025
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
A Phase 4 trial of ezetimibe in atherosclerotic cardiovascular disease (ASCVD), hypercholesterolemia, sponsored by University of Porto. Started Jun 2025; status: recruiting.
02
Drugs
ezetimibe
03
Conditions
atherosclerotic cardiovascular disease (ASCVD)hypercholesterolemia
Beyond the preview
Go deeper on NCT07839741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07839741.